Long-Term Metformin Treatment and Risk of Peripheral Neuropathy in Older Veterans

The prevalence of type 2 diabetes mellitus (T2DM) in aging adults in the U.S. has risen dramatically, particularly among U.S. Veterans, where it currently affects over 20% of the Veteran population [1]. Metformin is recommended as a first line treatment for individuals with T2DM and normal kidney function, resulting in nearly 70% of all U.S. Veterans receiving metformin to treat their T2DM [2].

Source: Diabetes Research and Clinical Practice - October 5, 2020 Category: Endocrinology Authors: Monica C. Serra, Vijaya Kancherla, Anjali Khakharia, Latricia L. Allen, Lawrence S. Phillips, Mary K. Rhee, Peter W.F. Wilson, Camille P. Vaughan Source Type: research